Inventor · disambiguated record
Mary Newman
Also filed as: NEWMAN MARY · NEWMAN MARY B
6 granted patents·6 pending applications·54 citations·filing 2001–2021
83Inventor score
Top patents by PatentIndex Score
12 records- 0193US6734215B2Exo-S-mecamylamine formulation and use in treatmentUNIV SOUTH FLORIDA·Filed 2001·Granted May 11, 2004·28 cites·11 claims
- 0289US8026283B2Exo-S-mecamylamine formulation and use in treatmentUNIV SOUTH FLORIDA·Filed 2010·Granted Sep 27, 2011·5 cites·4 claims
- 0386US7101916B2Exo-S-mecamylamine formulation and use in treatmentUNIV SOUTH FLORIDA·Filed 2003·Granted Sep 5, 2006·18 cites·32 claims
- 0481US11058677B2LFA-1 inhibitor formulationsNOVARTIS AG·Filed 2013·Granted Jul 13, 2021·2 cites·21 claims
- 0581US9593070B2Exo-S-mecamylamine formulation and use in treatmentUNIV SOUTH FLORIDA·Filed 2014·Granted Mar 14, 2017·1 cites·6 claims
- 0675US10188613B2Exo-S-mecamylamine formulation and use in treatmentUNIV SOUTH FLORIDA·Filed 2018·Granted Jan 29, 2019·0 cites·11 claims
- 0766US2006276551A1Exo-S-Mecamylamine Formulation and Use in TreatmentSHYTLE DOUGLAS·Filed 2006·Application pending·0 cites
- 0863US2022000859A1Lfa-1 inhibitor formulationsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0961US2017181983A1Exo-s-mecamylamine formulation and use in treatmentSHYTLE DOUGLAS·Filed 2017·Application pending·0 cites
- 1055US2011028565A1Exo-s-mecamylamine formulation and use in treatmentUNIV SOUTH FLORIDA·Filed 2010·Application pending·0 cites
- 1147US2006159666A1Method of potentiating inflammatory and immune modulation for cell and drug therapyWILLING ALISON E·Filed 2005·Application pending·0 cites
- 1237US2002016370A1Exo-R-mecamylamine formulation and use in treatmentFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →